460
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Parenthood in patients with acute promyelocytic leukemia after treatment with arsenic trioxide: a case series

, , , , , & show all
Pages 2192-2194 | Received 06 Mar 2012, Accepted 22 Mar 2012, Published online: 30 Apr 2012

References

  • Douer D. The epidemiology of acute promyelocytic leukaemia. Balliere's Best Pract Clin Hematol 2003;16:357–367.
  • Zhou G-B, Zhao W-L, Wang Z-Y, . Retinoic acid and arsenic for treating acute promyelocytic leukaemia. PLoS Med 2005;2:e12.
  • Ghavamzadeh A, Alimoghaddam K, Rostami S, . Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia. J Clin Oncol 2011;29:2753–2757.
  • Advani S, Nair R, Nair C, . Acute promyelocytic leukaemia: all trans retinoic acid along with daunomycin followed by arsenic trioxide as sequential therapy. Proc Am Soc Clin Oncol 2001;20: Abstract 1213.
  • Mathews V, George B, Jijina F, . Single agent arsenic trioxide regimen for the treatment of newly diagnosed acute promyelocytic leukaemia: initial results of a multicenter randomized controlled study from India to study the optimal duration of arsenic trioxide maintenance therapy (IAPLSG04). Blood 2008;112(Suppl. 1): Abstract 2082.
  • Spitz S. The histological effects of nitrogen mustard in human tissues and tumours. Cancer 1948;1:393–398.
  • Fossa SD, Magelssen H. Fertility and reproduction after chemotherapy of adult cancer patients: malignant lymphoma and testicular cancer. Ann Oncol 2004;15(Suppl. 4):iv259–iv265.
  • Wang A, Holladay SD, Wolf DC, . Reproductive and developmental toxicity of arsenic in rodents: a review. Int J Toxicol 2006;25:319–331.
  • Cvancarova M, Samuelsen SO, Magelssen H, . Reproduction rates after cancer treatment: experience from the Norwegian Radium Hospital. J Clin Oncol 2009;27:334–343.
  • Madanat L-MS, Malila N, Dyba T, . Probability of parenthood after early onset cancer: a population-based study. Int J Cancer 2008;123:2891–2898.
  • Kiserud CE, Fossa A, Holte H, . Post-treatment parenthood in Hodgkin's lymphoma survivors. Br J Cancer 2007;96:1442–1449.
  • Anselmo AP, Cartoni C, Bellantuono P, . Risk of infertility in patients with Hodgkin's disease treated with ABVD vs. MOPP vs. ABVD/MOPP. Haematologica 1990;75:155–158.
  • van der Kaaij MAE, Heutte N, Meijnders P, . Parenthood in survivors of Hodgkin lymphoma: an EORTC-GELA general population case-control study. J Clin Oncol 2011;29(Suppl.): Abstract 9062.
  • Fosså SD, Magelssen H, Melve K, . Parenthood in survivors after adulthood cancer and perinatal health in their offspring: a preliminary report. J Natl Cancer Inst Monograms 2005;(34):77–82.
  • Ståhl O, Boyd HA, Giwercman A, . Risk of birth abnormalities in the offspring of men with a history of cancer: a cohort study using Danish and Swedish national registries. J Natl Cancer Inst 2011;103:398–406.
  • Bencko V. Carcinogenic, teratogenic, and mutagenic effects of arsenic. Environ Health Perspect 1977;19:179–182.
  • Dessesso JM. Teratogen update: inorganic arsenic. Teratology 2001;63:170–173.
  • Ammatuna E, Cavaliere A, Divona M, . Successful pregnancy after arsenic trioxide therapy for relapsed acute promyelocytic leukaemia. Br J Haematol 2009;146:333–344.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.